Be part of the knowledge.™

Spotlight On Alzheimer's Disease

More than 6 million Americans are currently living with Alzheimer's, and that number is only expected to increase. In fact, estimates now show that this number could rise to nearly 13 million by 2050.

To help optimize the care of patients living with this debilitating condition, Spotlight on Alzheimer’s Disease features leading neurologists and other allied healthcare professionals sharing their insights on the latest diagnostic and treatment advances.

194

LikeLikedUnlike

Episodes 1-15 of 28

Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
NeuroFrontiers
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
- Marc Haut, PhD
  Peer
Transforming Alzheimer’s Care: Anti-Amyloid Therapies and Emerging Genetic Approaches
NeuroFrontiers
Transforming Alzheimer’s Care: Anti-Amyloid Therapies and Emerging Genetic Approaches
- Marc Haut, PhD
  Peer
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
NeuroFrontiers
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
- David Gate, PhD
  Peer
Restoring Immune Balance: Low-Dose IL-2 Shows Promise in Alzheimer’s Research
NeuroFrontiers
Restoring Immune Balance: Low-Dose IL-2 Shows Promise in Alzheimer’s Research
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
NeuroFrontiers
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
NeuroFrontiers
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
advertisement
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiers
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
- Thomas Karikari, PhD
  Peer
Preventing Alzheimer’s Disease Through Lifestyle Interventions
NeuroFrontiers
Preventing Alzheimer’s Disease Through Lifestyle Interventions
- Michele Longo, MD
  Peer
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
NeuroFrontiers
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
- Michele Longo, MD
  Peer
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
NeuroFrontiers
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jasmohan Bajaj, MD
  Peer
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
NeuroFrontiers
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Dr. Robert J. Shmookler Reis, PhD
  Peer
- Dr. Srinivas Ayyadevara, PhD
  Peer
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
NeuroFrontiers
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
- Ashley Baker, MSN, PMHNP
  Peer
- Istvan Mody, PhD
  Peer
advertisement
Public Health Disparities in Alzheimer's Disease and Brain Health
NeuroFrontiers
Public Health Disparities in Alzheimer's Disease and Brain Health
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
NeuroFrontiers
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jagan Pillai, MD, PhD
  Peer
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
NeuroFrontiers
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Marcus E. Peter, PhD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended